Sugi Predict

Sugi Predict / Compounds / SCHEMBL961145

SCHEMBL961145

SCHEMBL961145

CCCCCC[n+]1ccn(CCC)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.54
▸ HSP90AA1 P07900 2/20 0.54
▸ KMT2A Q03164 2/20 0.54
▸ SMN1; SMN2 Q16637 2/20 0.54
▸ APAF1 O14727 1/20 0.51
▸ NPC1 O15118 1/20 0.51
▸ PLA2G1B P04054 1/20 0.51
▸ MAPT P10636 1/20 0.51
▸ MAPK1 P28482 1/20 0.51
▸ HTT P42858 1/20 0.51
▸ RAB9A P51151 1/20 0.51
▸ NPSR1 Q6W5P4 1/20 0.51
▸ ATG4B Q9Y4P1 1/20 0.51
▸ ABCB11 O95342 1/20 0.47
▸ ESR1 P03372 1/20 0.47
▸ PGR P06401 1/20 0.47
▸ CHRM2 P08172 1/20 0.47
▸ HTR1A P08908 1/20 0.47
▸ ADRA2A P08913 1/20 0.47
▸ ADORA3 P0DMS8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5282928 1.00 MEN1 (0.54) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL5301568 1.00 MEN1 (0.54) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL5290111 1.00 MEN1 (0.54) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL5289993 1.00 MEN1 (0.54) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL5286003 1.00 MEN1 (0.54) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL5298507 1.00 MEN1 (0.54) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL5291547 1.00 MEN1 (0.54) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL5292001 1.00 MEN1 (0.54) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL5288554 1.00 MEN1 (0.54) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL5288672 1.00 MEN1 (0.54) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9267214-B2 Aluminum recovery process BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) 2016-02-23 — — US claimed
US-20110000782-A1 ALUMINUM RECOVERY PROCESS THE UNIVERSITY OF ALABAMA (US) 2011-01-06 — — US claimed
WO-2009102419-A2 ALUMINUM RECOVERY PROCESS THE UNIVERSITY OF ALABAMA (US) 2009-08-20 — — WO claimed
US-12291506-B2 Method for producing amidate compound, and amidate compound KOEI CHEMICAL COMPANY, LIMITED (JP) 2025-05-06 — — US disclosed
CN-118290346-A Method for producing amide compound, and amide compound 广荣化学株式会社 2024-07-05 — — CN disclosed
CN-112703184-B Method for producing amide compound, and amide compound 广荣化学株式会社 2024-06-11 — — CN disclosed
CN-117043136-A Fluorine-based ionic liquid and method for producing same 第一工业制药株式会社 2023-11-10 — — CN disclosed
WO-2022209538-A1 FLUORINE-BASED IONIC LIQUID AND PRODUCTION METHOD THEREOF 第一工業製薬株式会社 2022-10-06 — — WO disclosed
US-20220048864-A1 METHOD FOR PRODUCING AMIDATE COMPOUND, AND AMIDATE COMPOUND KOEI CHEMICAL COMPANY, LIMITED (JP) 2022-02-17 — — US disclosed
EP-3858817-A1 METHOD FOR PRODUCING AMIDATE COMPOUND, AND AMIDATE COMPOUND Koei Chemical Company, Limited (JP) 2021-08-04 — — EP disclosed
CN-112703184-A Process for producing amide compound, and amide compound 广荣化学株式会社 2021-04-23 — — CN disclosed
US-8227690-B2 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2012-07-24 — — US disclosed
US-20110000782-A1 ALUMINUM RECOVERY PROCESS THE UNIVERSITY OF ALABAMA (US) 2011-01-06 — — US disclosed
WO-2009131692-A1 SUBSTRATES FOR DELIVERY OF PHYSIOLOGICALLY ACTIVE AGENTS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) 2009-10-29 — — WO disclosed
US-7605271-B2 Superhigh purity ionic liquid DAI-ICHI KOGYO SEIYAKU CO., LTD (JP) 2009-10-20 — — US disclosed
WO-2009102419-A2 ALUMINUM RECOVERY PROCESS THE UNIVERSITY OF ALABAMA (US) 2009-08-20 — — WO disclosed
WO-2007006418-A1 IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2007-01-18 — — WO disclosed
WO-2006131234-A1 COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-12-14 — — WO disclosed
US-20060223995-A1 Superhigh purity ionic liquid DAI-ICHI KOGYO SEIYAKU CO., LTD. (JP) 2006-10-05 — — US disclosed
EP-1707265-A1 Superhigh purity ionic liquid DAI-ICHI KOGYO SEIYAKU CO., LTD. (JP) 2006-10-04 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12291506-B2 Method for producing amidate compound, and amidate compound NAAA, NIT2, PAM MEN1 55/4885HSP90AA1 4241/4885KMT2A 4207/4885
US-20060223995-A1 Superhigh purity ionic liquid SLC7A5, SLC7A1, SLC43A1 MEN1 1382/4885HSP90AA1 4501/4885KMT2A 643/4885
US-20220048864-A1 METHOD FOR PRODUCING AMIDATE COMPOUND, AND AMIDATE COMPOUND NAAA, NIT2, PAM MEN1 55/4885HSP90AA1 4241/4885KMT2A 4207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.